124 related articles for article (PubMed ID: 9753283)
21. Three-dimensional computed tomographic cholangiography as a novel diagnostic tool for evaluation of bile duct invasion of perihilar cholangiocarcinoma.
Ajiki T; Fukumoto T; Ueno K; Okazaki T; Matsumoto I; Ku Y
Hepatogastroenterology; 2013; 60(128):1833-8. PubMed ID: 24719915
[TBL] [Abstract][Full Text] [Related]
22. High-dose rate intraluminal brachytherapy: An effective palliation for cholangiocarcinoma causing bile duct obstruction.
Nguyen NA; Timotin E; Hunter R; Sur RK
Surg Oncol; 2018 Dec; 27(4):625-629. PubMed ID: 30449482
[No Abstract] [Full Text] [Related]
23. Leakage via aberrant bile duct due to cholangiocarcinoma.
Stanton R; Craig PI; Jorgensen JO; Morris DL
HPB Surg; 1998; 11(2):125-8. PubMed ID: 9893244
[TBL] [Abstract][Full Text] [Related]
24. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.
Freeman ML; Overby C
Gastrointest Endosc; 2003 Jul; 58(1):41-9. PubMed ID: 12838219
[TBL] [Abstract][Full Text] [Related]
25. Biliary ascariasis and extrahepatic cholangiocarcinoma: a report of two cases.
Lim KG; Sellaiah SP
Singapore Med J; 1994 Aug; 35(4):400-2. PubMed ID: 7899902
[TBL] [Abstract][Full Text] [Related]
26. Recurrent cholangitis in a 65-year-old man. Biliary papillomatosis.
Joosse ME; Schipper ME; Libbrecht L; van Buuren HR; de Man RA
Gut; 2015 Jun; 64(6):883, 910. PubMed ID: 25533647
[No Abstract] [Full Text] [Related]
27. Combined T/Y biliary stent placement for the treatment of biliary obstruction caused by Bismuth-Corlett type IV hilar cholangiocarcinoma.
Li TF; Li Z; Han XW; Ren JZ; Jiao C; Bi YH; Ren KW
Hepatogastroenterology; 2014 Sep; 61(134):1519-22. PubMed ID: 25436335
[TBL] [Abstract][Full Text] [Related]
28. Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case.
Sano T; Yamamoto J; Kosuge T; Inoue K; Shimada K; Takayama T; Yamazaki S; Sakamoto M; Hirohashi S
Hepatogastroenterology; 1996; 43(9):667-70. PubMed ID: 8799413
[TBL] [Abstract][Full Text] [Related]
29. Primary or metastatic hepatic carcinoma? A breast cancer patient after adjuvant chemotherapy and radiotherapy postoperatively with intrahepatic cholangiocarcinoma and review of the literature.
Liu ZY; Sun JJ; He KW; Zhuo PY; Yu ZY
World J Surg Oncol; 2016 Jul; 14(1):183. PubMed ID: 27422708
[TBL] [Abstract][Full Text] [Related]
30. Cholangiocarcinoma arising from preexisting biliary hamartoma of liver--report of a case.
Orii T; Ohkohchi N; Sasaki K; Satomi S; Watanabe M; Moriya T
Hepatogastroenterology; 2003; 50(50):333-6. PubMed ID: 12749215
[TBL] [Abstract][Full Text] [Related]
31. BRAF V600E mutation in biliary proliferations associated with α
Angkathunyakul N; Rosini F; Heaton N; Foskett P; Quaglia A
Histopathology; 2017 Feb; 70(3):485-491. PubMed ID: 27627051
[TBL] [Abstract][Full Text] [Related]
32. Utility of EUS in patients with indeterminate biliary strictures and suspected extrahepatic cholangiocarcinoma (with videos).
Khashab MA; Fockens P; Al-Haddad MA
Gastrointest Endosc; 2012 Nov; 76(5):1024-33. PubMed ID: 22749367
[No Abstract] [Full Text] [Related]
33. Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center.
Brandi G; Venturi M; Pantaleo MA; Ercolani G;
Dig Liver Dis; 2016 Mar; 48(3):231-41. PubMed ID: 26769568
[TBL] [Abstract][Full Text] [Related]
34. Portal vein stenting for portal vein stenosis caused by bile duct cancer.
Kamata K; Takenaka M; Tsurusaki M; Kudo M
Dig Liver Dis; 2017 Nov; 49(11):1282. PubMed ID: 28676419
[No Abstract] [Full Text] [Related]
35. Endoscopic stenting in bile duct cancer increases liver volume.
Lee CH; Kim SH; Kim IH; Kim SW; Lee ST; Kim DG; Yang JD; Yu HC; Cho BH; Lee SO
Gastrointest Endosc; 2014 Sep; 80(3):447-55. PubMed ID: 24679659
[TBL] [Abstract][Full Text] [Related]
36. Heterotopic Gastric Mucosa in the Common Bile Duct With Cholangiocarcinoma.
Kim Y; Jung MJ; Shin SJ
Int J Surg Pathol; 2018 Dec; 26(8):745-748. PubMed ID: 29742955
[TBL] [Abstract][Full Text] [Related]
37. [Pathology of gallbladder and extrahepatic bile ducts. Case 6. Well- differentiated hilar cholangiocarcinoma pT2bN1].
Guettier C
Ann Pathol; 2014 Aug; 34(4):309-14. PubMed ID: 25132442
[No Abstract] [Full Text] [Related]
38. Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Moreno Luna LE; Gores GJ
Liver Transpl; 2006 Nov; 12(11 Suppl 2):S15-9. PubMed ID: 17051561
[No Abstract] [Full Text] [Related]
39. Endoscopic cholecystogastrostomy in a patient with gallbladder empyema secondary to cholangiocarcinoma.
Paranandi B; Nayar M; Scott J; Charnley R; Wilson C; Oppong K
Endoscopy; 2016; 48 Suppl 1():E163. PubMed ID: 27116100
[No Abstract] [Full Text] [Related]
40. Intrahepatic cholangiocarcinoma associated with central calcification and arterio-portal shunt.
Kitade M; Yoshiji H; Yamao J; Fujimoto M; Kojima H; Mitoro A; Yoshida M; Namisaki T; Yamazaki M; Toyohara M; Uemura M; Fukui H
Intern Med; 2005 Aug; 44(8):825-8. PubMed ID: 16157980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
